Caladrius Biosciences, Inc. (LSTA) Tops Q3 EPS by 16c
Tweet
Share
E-mailGet Alerts LSTA Hot Sheet
Join SI Premium – FREE
Caladrius Biosciences, Inc. (NASDAQ: LSTA) reported Q3 EPS of ($0.59), $0.16 better than the analyst estimate of ($0.75).
For earnings history and earnings-related data on Caladrius Biosciences, Inc. (LSTA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Downgrades Core Natural Resources (CNR) to Neutral
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- Jack Henry (JKHY) Tops Q4 EPS by 13c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
